Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN67,9367,96-0,73
Msft429,3429,378,63
Nokia4,3854,451,06
IBM239,97240,12-0,72
Mercedes-Benz Group AG52,6252,65-2,73
PFE24,0324,04-1,54
01.05.2025 19:22:51
Indexy online
AD Index online
select
AD Index online
 

  • 01.05.2025 19:22:22
Intuitive Surgical (ISRG.O, NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
519,34 0,69 3,54 735 626
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 01.05.2025
Popis společnosti
Obecné informace
Název společnostiIntuitive Surgical Inc
TickerISRG
Kmenové akcie:Ordinary Shares
RICISRG.O
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky31.03.2025
Počet zaměstnanců k 31.12.2024 15 638
Akcie v oběhu k 15.04.2025 358 418 255
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
Ulice1020 Kifer Road
MěstoSUNNYVALE
PSČ94086
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon14 085 232 100
Fax14085231390

Business Summary: Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.
Financial Summary: BRIEF: For the three months ended 31 March 2025, Intuitive Surgical Inc revenues increased 19% to $2.25B. Net income increased 28% to $698.4M. Revenues reflect Instruments and accessories increase of 18% to $1.37B, Systems increase of 25% to $522.7M, Service increase of 16% to $363M. Basic Earnings per Share excluding Extraordinary Items increased from $1.54 to $1.95.
Odvětvová klasifikace
TRBC2009Advanced Medical Equipment
TRBC2012Advanced Medical Equipment & Technology (NEC)
RBSS2004Advanced Medical Equipment
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
NAICSSurgical Appliance and Supplies Manufacturing
NAICS2007Electromedical Apparatus Mfg
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Surgical Appliance & Supplies Mfg
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Surgical Appliance and Supplies Manufacturing
SICSurgical Appliances And Supplies
SICElectromedical Equipment
SICSurgical And Medical Instruments
SICSurgical Appliances And Supplies



  • Poslední aktualizace: 01.05.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, DirectorDavid Rosa5724.07.202401.01.2011
Chief Executive Officer, DirectorGary Guthart5916.05.2023
Executive Vice President, Chief Financial Officer, Head of Business TechnologyJamie Samath5401.01.2025
Executive Vice President, Chief Strategy and Corporate Operations OfficerBob DeSantis60
Executive Vice President, Chief Commercial and Marketing OfficerHenry Charlton5501.01.2025
Executive Vice President, Chief Legal and Compliance OfficerGary Loeb5503.01.202527.09.2022
Executive Vice President, Chief Medical OfficerMyriam Curet68
Executive Vice President, Chief Digital OfficerBrian Miller50
Senior Vice President, Chief Manufacturing and Supply Chain OfficerMark Brosius58